Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Netherlands
  4. Euronext Amsterdam
  5. Royal DSM N.V.
  6. News
  7. Summary
    DSM   NL0000009827

ROYAL DSM N.V.

(DSM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Koninklijke DSM N.V. acquired remaining 61.5% stake in Midori USA, Inc for $63 million.

07/27/2021 EDT

Koninklijke DSM N.V. (ENXTAM:DSM) acquired remaining 61.5% stake in Midori USA, Inc for $63 million on July 27, 2021. Koninklijke DSM N.V. (ENXTAM:DSM) completed the acquisition remaining of 61.5% stake in Midori USA, Inc on July 27, 2021.


ę S&P Capital IQ 2021
All news about ROYAL DSM N.V.
09/14DSM Starts A Review of Strategic Options
CI
09/14ROYAL DSM N : Koninklijke DSM N.V., - DSM accelerates its strategic journey to a fully foc..
PU
09/14Europe ends flat as miners, luxury stocks weigh; inflation optimism cools
RE
09/14ROYAL DSM N : Koninklijke DSM N.V., - DSM announces food system commitments to set a healt..
PU
09/14ROYAL DSM N : DSM prefers direct sale of materials division, CEO says
RE
09/14ROYAL DSM N : Dutch DSM to exit materials to focus on food, health and climate
RE
09/14ROYAL DSM N : DSM Begins Strategic Review of Materials Businesses in Health-Focused Shift
MT
09/14ROYAL DSM N : DSM Targets Livestock Emission Cuts In Set of Food System Commitments For 20..
MT
09/14ROYAL DSM N : DSM announces food system commitments to set a healthier future for people, ..
PU
09/14ROYAL DSM N : DSM accelerates its strategic journey to a fully focused Health, Nutrition &..
PU
More news
Analyst Recommendations on ROYAL DSM N.V.
More recommendations
Financials
Sales 2021 8 957 M 10 501 M 10 501 M
Net income 2021 1 332 M 1 561 M 1 561 M
Net Debt 2021 1 135 M 1 330 M 1 330 M
P/E ratio 2021 21,4x
Yield 2021 1,37%
Capitalization 31 681 M 37 123 M 37 140 M
EV / Sales 2021 3,66x
EV / Sales 2022 3,45x
Nbr of Employees 21 173
Free-Float 91,1%
Chart ROYAL DSM N.V.
Duration : Period :
Royal DSM N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ROYAL DSM N.V.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Last Close Price 185,50 €
Average target price 181,51 €
Spread / Average Target -2,15%
EPS Revisions
Managers and Directors
Dimitri de Vreeze Co-Chief Executive Officer & COO
GÚraldine Matchett Co-Chief Executive Officer & CFO
Thomas Leysen Chairman-Supervisory Board
Eileen A. Kennedy Member-Supervisory Board
Pradeep Pant Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
ROYAL DSM N.V.30.40%36 799
SHIN-ETSU CHEMICAL CO., LTD.17.24%80 890
BASF SE-4.56%66 582
DUPONT DE NEMOURS, INC.-4.47%35 531
PIDILITE INDUSTRIES LIMITED37.47%16 286
ASAHI KASEI CORPORATION17.92%16 033